Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 GBX | +7.50% | +4.88% | -67.91% |
May. 28 | NetScientific backs Wanda; Inspirit Energy wins deal | AN |
May. 10 | Shield Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 24.13M 30.7M | Sales 2025 * | 71.12M 90.47M | Capitalization | 16.81M 21.39M |
---|---|---|---|---|---|
Net income 2024 * | -18M -22.9M | Net income 2025 * | 3M 3.82M | EV / Sales 2024 * | 1.64 x |
Net Debt 2024 * | 22.86M 29.07M | Net Debt 2025 * | 20.43M 25.99M | EV / Sales 2025 * | 0.52 x |
P/E ratio 2024 * |
-0.92
x | P/E ratio 2025 * |
4.93
x | Employees | 73 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 43.82% |
Latest transcript on Shield Therapeutics plc
1 day | +7.50% | ||
1 week | +4.88% | ||
Current month | +4.88% | ||
1 month | +38.71% | ||
3 months | -14.85% | ||
6 months | -65.60% | ||
Current year | -67.91% |
Managers | Title | Age | Since |
---|---|---|---|
Gregory Madison
CEO | Chief Executive Officer | 57 | 21-05-31 |
Santosh Shanbhag
DFI | Director of Finance/CFO | 47 | Jan. 15 |
David Childs
COO | Chief Operating Officer | - | 11-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 18-07-25 | |
Director/Board Member | 66 | 16-01-31 | |
Director/Board Member | 57 | 21-05-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 2.15 | +7.50% | 2,572,355 |
24-06-06 | 2 | +8.11% | 2,532,367 |
24-06-05 | 1.85 | -2.63% | 2,573,304 |
24-06-04 | 1.9 | +2.70% | 647,775 |
24-06-03 | 1.85 | -9.76% | 3,046,310 |
Delayed Quote London S.E., June 07, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-67.91% | 21.39M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- STX Stock